Question

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

5 comments5

Total Forecasters45

Community Prediction4% (2% - 10.1%)

Make a Prediction

50%

community: 4%

Learn more about scores here.

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Warning as experts discover weight loss jabs like Ozempic render breast cancer chemo ineffective

Daily Mail•Dec 13, 2024

Obesity, body mass decrease in the U.S. for the first time in over a decade

Independent•Dec 14, 2024

Ozempic Being Abused, Warns Obesity Doctor

Newsweek•Dec 14, 2024

Learn more about Metaculus NewsMatch

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

0.7%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Warning as experts discover weight loss jabs like Ozempic render breast cancer chemo ineffective

Daily Mail•Dec 13, 2024

Obesity, body mass decrease in the U.S. for the first time in over a decade

Independent•Dec 14, 2024

Ozempic Being Abused, Warns Obesity Doctor

Newsweek•Dec 14, 2024

Learn more about Metaculus NewsMatch

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

0.7%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Take Our 🏆Quarterly Cup🏆 Survey

MetaculusM

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Make a Prediction

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Comments

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?